Hypercalcemia as the main clinical issue can almost always be sufficiently controlled as well as hypophosphatemia, PTH levels may be lowered, and cognitive as well as HRQOL parameters improve with the treatment. The gene discussed is PTH; the disease is hypercalcemia disease.